CVS Health (CVS) Revenue — Quarter Ended Dec 31, 2025
Revenue for the quarter ended December 31, 2025 increased compared with both the preceding quarter and the same quarter a year earlier. The reported direction reflects sustained year-over-year growth and a sequential acceleration in the final fiscal period.
Key takeaway
Quarter ended Dec 31, 2025 · FY2025 Q4
Revenue for the quarter ended December 31, 2025 increased compared with both the preceding quarter and the same quarter a year earlier. The reported direction reflects sustained year-over-year growth and a sequential acceleration in the final fiscal period.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$105.7B
Revenue reported for this quarter.
Quarter-over-quarter
+2.7%
Change from the immediately preceding quarter.
Year-over-year
+8.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$402.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2025 | $94.6B | +7.0% |
| Jun 30, 2025 | $98.9B | +8.4% |
| Sep 30, 2025 | $102.9B | +7.8% |
| Dec 31, 2025 | $105.7B | +8.2% |
Revenue performance
Revenue rose from the immediately preceding quarter, and also increased compared with the same quarter one year prior. The trailing twelve-month revenue figure underscores the full-year scale of operations.
Quarterly comparison
Relative to both the prior quarter and the same quarter last year, revenue improved. The sequential increase marks a continuation of the positive quarterly trend observed throughout the fiscal year.
What to watch
The filing context is empty of detail regarding specific drivers; monitor future filings for commentary on the factors behind the reported revenue motion.